These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32250532)

  • 1. Recessive congenital myasthenic syndrome caused by a homozygous mutation in SYT2 altering a highly conserved C-terminal amino acid sequence.
    Maselli RA; van der Linden H; Ferns M
    Am J Med Genet A; 2020 Jul; 182(7):1744-1749. PubMed ID: 32250532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant and recessive congenital myasthenic syndromes caused by SYT2 mutations.
    Maselli RA; Wei DT; Hodgson TS; Sampson JB; Vazquez J; Smith HL; Pytel P; Ferns M
    Muscle Nerve; 2021 Aug; 64(2):219-224. PubMed ID: 34037996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome.
    Donkervoort S; Mohassel P; Laugwitz L; Zaki MS; Kamsteeg EJ; Maroofian R; Chao KR; Verschuuren-Bemelmans CC; Horber V; Fock AJM; McCarty RM; Jain MS; Biancavilla V; McMacken G; Nalls M; Voermans NC; Elbendary HM; Snyder M; Cai C; Lehky TJ; Stanley V; Iannaccone ST; Foley AR; Lochmüller H; Gleeson J; Houlden H; Haack TB; Horvath R; Bönnemann CG
    Am J Med Genet A; 2020 Oct; 182(10):2272-2283. PubMed ID: 32776697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to Spot Congenital Myasthenic Syndromes Resembling the Lambert-Eaton Myasthenic Syndrome? A Brief Review of Clinical, Electrophysiological, and Genetics Features.
    Lorenzoni PJ; Scola RH; Kay CSK; Werneck LC; Horvath R; Lochmüller H
    Neuromolecular Med; 2018 Jun; 20(2):205-214. PubMed ID: 29696584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy.
    Herrmann DN; Horvath R; Sowden JE; Gonzalez M; Sanchez-Mejias A; Guan Z; Whittaker RG; Almodovar JL; Lane M; Bansagi B; Pyle A; Boczonadi V; Lochmüller H; Griffin H; Chinnery PF; Lloyd TE; Littleton JT; Zuchner S
    Am J Hum Genet; 2014 Sep; 95(3):332-9. PubMed ID: 25192047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A presynaptic congenital myasthenic syndrome attributed to a homozygous sequence variant in LAMA5.
    Maselli RA; Arredondo J; Vázquez J; Chong JX; Bamshad MJ; Nickerson DA; Lara M; Ng F; Lo VL; Pytel P; McDonald CM
    Ann N Y Acad Sci; 2018 Feb; 1413(1):119-125. PubMed ID: 29377152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
    Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
    Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrostigmine therapy in a patient with VAMP1-related congenital myasthenic syndrome.
    Al-Muhaizea MA; AlQuait L; AlRasheed A; AlHarbi S; Albader AA; AlMass R; Albakheet A; Alhumaidan A; AlRasheed MM; Colak D; Kaya N
    Neuromuscul Disord; 2020 Jul; 30(7):611-615. PubMed ID: 32616363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome.
    Whittaker RG; Herrmann DN; Bansagi B; Hasan BA; Lofra RM; Logigian EL; Sowden JE; Almodovar JL; Littleton JT; Zuchner S; Horvath R; Lochmüller H
    Neurology; 2015 Dec; 85(22):1964-71. PubMed ID: 26519543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new de novo SYT2 mutation presenting as distal weakness. Neuropathy or neuromuscular junction dysfunction?
    Fionda L; Turon-Sans J; Fuentes Prior P; Bernal Noguera S; Cortés-Vicente E; López-Pérez MA; Gallardo E; Rojas-García R
    J Peripher Nerv Syst; 2021 Mar; 26(1):113-117. PubMed ID: 33320396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New recessive mutations in
    Bauché S; Sureau A; Sternberg D; Rendu J; Buon C; Messéant J; Boëx M; Furling D; Fauré J; Latypova X; Gelot AB; Mayer M; Mary P; Whalen S; Fournier E; Cloix I; Remerand G; Laffargue F; Nougues MC; Fontaine B; Eymard B; Isapof A; Strochlic L
    Neurol Genet; 2020 Dec; 6(6):e534. PubMed ID: 33659639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drosophila studies support a role for a presynaptic synaptotagmin mutation in a human congenital myasthenic syndrome.
    Shields MC; Bowers MR; Fulcer MM; Bollig MK; Rock PJ; Sutton BR; Vrailas-Mortimer AD; Lochmüller H; Whittaker RG; Horvath R; Reist NE
    PLoS One; 2017; 12(9):e0184817. PubMed ID: 28953919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic congenital myasthenic syndrome with altered synaptic vesicle homeostasis linked to compound heterozygous sequence variants in RPH3A.
    Maselli RA; Vázquez J; Schrumpf L; Arredondo J; Lara M; Strober JB; Pytel P; Wollmann RL; Ferns M
    Mol Genet Genomic Med; 2018 May; 6(3):434-440. PubMed ID: 29441694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission.
    Maselli RA; Arredondo J; Vázquez J; Chong JX; ; Bamshad MJ; Nickerson DA; Lara M; Ng F; Lo VL; Pytel P; McDonald CM
    Am J Med Genet A; 2017 Aug; 173(8):2240-2245. PubMed ID: 28544784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes - A recognizable clinical phenotype.
    Polavarapu K; Vengalil S; Preethish-Kumar V; Arunachal G; Nashi S; Mohan D; Chawla T; Bardhan M; Nandeesh B; Gupta P; Gowda VK; Lochmüller H; Nalini A
    Eur J Paediatr Neurol; 2021 Mar; 31():54-60. PubMed ID: 33631708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
    Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
    Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
    Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects on fast exocytosis induced by synaptotagmin 1 and 2 isoforms and abundance but not by phosphorylation.
    Nagy G; Kim JH; Pang ZP; Matti U; Rettig J; Südhof TC; Sørensen JB
    J Neurosci; 2006 Jan; 26(2):632-43. PubMed ID: 16407561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing and microarray identified a novel large exonic deletion in
    Kumar CPR; Tamhankar PM; Manohar R; Sharda S; Madhavilatha GK; Thenral SG; Nair S; Bojamma AK
    J Genet; 2023; 102():. PubMed ID: 36722210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.